ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for tools Level up your trading with our powerful tools and real-time insights all in one place.
Lumibird

Lumibird (LBIRD)

9.08
0.08
(0.89%)
Closed 26 December 3:30AM

Real-time discussions and trading ideas: Trade with confidence with our powerful platform.

Key stats and details

Current Price
9.08
Bid
8.50
Offer
9.18
Volume
2,523
8.88 Day's Range 9.08
6.78 52 Week Range 15.48
Market Cap
Previous Close
9.00
Open
8.88
Last Trade
200
@
9.08
Last Trade Time
Financial Volume
-
VWAP
-
Average Volume (3m)
15,436
Shares Outstanding
22,228,377
Dividend Yield
-
PE Ratio
28.32
Earnings Per Share (EPS)
0.32
Revenue
207.91M
Net Profit
7.13M

About Lumibird

Sector
Electromedical Apparatus
Industry
Electromedical Apparatus
Headquarters
Saint-brieuc, Cotes-d'armor, Fra
Founded
-
Lumibird is listed in the Electromedical Apparatus sector of the Euronext with ticker LBIRD. The last closing price for Lumibird was 9.00 €. Over the last year, Lumibird shares have traded in a share price range of 6.78 € to 15.48 €.

Lumibird currently has 22,228,377 shares in issue. The market capitalisation of Lumibird is 200.06 € million. Lumibird has a price to earnings ratio (PE ratio) of 28.32.

LBIRD Latest News

Lumibird : nombre de droits de vote et d'actions au 30 novembre 2024

Lumibird : nombre de droits de vote et d'actions au 30 novembre 2024 Informations relatives au nombre total de droits de vote et d’actions prévues par les articles L.233-8 II du Code de...

LUMIBIRD: EXPLORATORY PROJECT TO SELL THE MEDICAL DIVISION

LUMIBIRD: EXPLORATORY PROJECT TO SELL THE MEDICAL DIVISION Lannion, November 27, 2024 – 8:00 am LUMIBIRD: EXPLORATORY PROJECT TO SELL THE MEDICAL DIVISION Following market rumours, Lumibird...

LUMIBIRD : PROJET EXPLORATOIRE DE VENTE DE LA DIVISION MEDICALE

LUMIBIRD : PROJET EXPLORATOIRE DE VENTE DE LA DIVISION MEDICALE Lannion, le 27 novembre 2024– 8h00 LUMIBIRD : PROJET EXPLORATOIRE DE VENTE DE LA DIVISION MEDICALE Suite à des rumeurs de marché...

Lumibird : nombre d'actions au 31 octobre 2024

Lumibird : nombre d'actions au 31 octobre 2024      Informations relatives au nombre total de droits de vote et d’actions prévues par les articles L.233-8 II du Code de commerce et 223-16 du...

LUMIBIRD : CHIFFRE D’AFFAIRES T3 - SIGNATURE D’UN ACCORD EN VUE DE L’ACQUISITION DE LA GAMME PRODUITS CONTINUUM AUPRÈS DU GROUPE AMPLITUDE LASER

LUMIBIRD : CHIFFRE D’AFFAIRES T3 - SIGNATURE D’UN ACCORD EN VUE DE L’ACQUISITION DE LA GAMME PRODUITS CONTINUUM AUPRÈS DU GROUPE AMPLITUDE LASER Lannion, 21 octobre 2024 – 17h55 CHIFFRE...

LUMIBIRD: Q3 REVENUE - AGREEMENT SIGNED TO ACQUIRE THE CONTINUUM PRODUCT RANGE FROM THE AMPLITUDE LASER GROUP

LUMIBIRD: Q3 REVENUE - AGREEMENT SIGNED TO ACQUIRE THE CONTINUUM PRODUCT RANGE FROM THE AMPLITUDE LASER GROUP Lannion, October 21, 2024 – 5:55 pm Q3 REVENUEAGREEMENT SIGNED TO ACQUIRE THE...

LUMIBIRD: BANKS RENEW THEIR CONFIDENCE IN THE GROUP'S STRATEGY WITH FINANCING OF OVER €100M

LUMIBIRD: BANKS RENEW THEIR CONFIDENCE IN THE GROUP'S STRATEGY WITH FINANCING OF OVER €100M Lannion, October 15, 2024 – 17:45 pm LUMIBIRD: BANKS RENEW THEIR CONFIDENCE IN THE GROUP'S...

LUMIBIRD : LES BANQUES RENOUVELLENT LEUR CONFIANCE DANS LA STRATÉGIE DU GROUPE VIA UN FINANCEMENT DE PLUS DE 100 M€

LUMIBIRD : LES BANQUES RENOUVELLENT LEUR CONFIANCE DANS LA STRATÉGIE DU GROUPE VIA UN FINANCEMENT DE PLUS DE 100 M€ Lannion, le 15 octobre 2024– 17h45 LUMIBIRD : LES BANQUES RENOUVELLENT LEUR...

Lumibird : nombre d'actions au 30 septembre 2024

Lumibird : nombre d'actions au 30 septembre 2024      Informations relatives au nombre total de droits de vote et d’actions prévues par les articles L.233-8 II du Code de commerce et...

LUMIBIRD : Rapport financier semestriel au 30 juin 2024

LUMIBIRD : Rapport financier semestriel au 30 juin 2024 LUMIBIRD : Rapport financier semestriel au 30 juin 2024 Pièce jointe Rapport financier semestriel LMB 2024-S1-VDEF

PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
1-0.12-1.304347826099.29.448.4142148.80952681DE
41.9827.88732394377.110.37.1232569.0709094DE
120.89.661835748798.2810.36.78154368.18998565DE
26-1.37-13.110047846910.4511.756.78118449.03704598DE
52-2.82-23.697478991611.915.486.781039110.61440342DE
156-14.72-61.848739495823.824.356.78799214.58085691DE
260-5.08-35.875706214714.1624.355.41086313.75902945DE

LBIRD - Frequently Asked Questions (FAQ)

What is the current Lumibird share price?
The current share price of Lumibird is 9.08 €
How many Lumibird shares are in issue?
Lumibird has 22,228,377 shares in issue
What is the market cap of Lumibird?
The market capitalisation of Lumibird is EUR 200.06M
What is the 1 year trading range for Lumibird share price?
Lumibird has traded in the range of 6.78 € to 15.48 € during the past year
What is the PE ratio of Lumibird?
The price to earnings ratio of Lumibird is 28.32
What is the cash to sales ratio of Lumibird?
The cash to sales ratio of Lumibird is 0.97
What is the reporting currency for Lumibird?
Lumibird reports financial results in EUR
What is the latest annual turnover for Lumibird?
The latest annual turnover of Lumibird is EUR 207.91M
What is the latest annual profit for Lumibird?
The latest annual profit of Lumibird is EUR 7.13M
What is the registered address of Lumibird?
The registered address for Lumibird is 2 RUE DU PAUL SABATIER, SAINT-BRIEUC, COTES-D'ARMOR, 22300
What is the Lumibird website address?
The website address for Lumibird is www.lumibird.com
Which industry sector does Lumibird operate in?
Lumibird operates in the ELECTROMEDICAL APPARATUS sector

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
EIFDSTour Eiffel DS
0.0432 €
(800.00%)
89.74k
SEQUASequana medical NV
2.76 €
(33.33%)
1.64M
ALEUPEuroplasma
0.0484 €
(28.38%)
6.54M
ALPAUPaulic Meunerie SA
1.43 €
(16.26%)
17.14k
GNROGeNeuro SA
0.081 €
(15.38%)
330.33k
MLSMLSmalto
0.0125 €
(-32.43%)
50
ALVIAVialife Sa
13.30 €
(-27.72%)
7
MLMADMade
9.25 €
(-15.91%)
255
ALALOAcheterLouerFR
0.23 €
(-14.81%)
3.92k
ALLPLLepermislibre SA
0.397 €
(-11.78%)
3.01k
ATOAtos SE
0.0023 €
(-4.17%)
396.59M
BCPBanco Comercial Portugues SA
0.451 €
(0.16%)
17.85M
LATLatecoere
0.0094 €
(3.30%)
9.13M
ALVERVergnet
0.0021 €
(-4.55%)
8.37M
ALEUPEuroplasma
0.0484 €
(28.38%)
6.54M

Discussion

View Full Feed
MasterBlastr MasterBlastr 1 minute ago
Simple monkey . . .
mauiguy2 mauiguy2 3 minutes ago
Absolutely! We were just there very recently.
CYBL
threewheeler threewheeler 3 minutes ago
KRTL liking what I.m seeing, hearing, next update can be huge
Xstocklpicker88
@xstocklpicker88
$KRTL at .046 is a #25xgem within 60 days imo. The company is an FDA registered pharma company bringing drugs from South America to the U.S. One sales news away from .046-1.00. The sta
KRTL MERRY NVDA
arizona1 arizona1 3 minutes ago
And the other 30% speak Danish. My daughter plays on a tennis team in Switzerland. The girls from the Italian part of the country came up to play a match and they didn't even speak German, only Italian. It was the strangest thing.
waterchaser waterchaser 3 minutes ago
Did you notice any warnings here on the IHUB Board about this company, its promoters and insiders?
HIRU
threewheeler threewheeler 3 minutes ago
KRTL liking what I.m seeing, hearing, next update can be huge
Xstocklpicker88
@xstocklpicker88
$KRTL at .046 is a #25xgem within 60 days imo. The company is an FDA registered pharma company bringing drugs from South America to the U.S. One sales news away from .046-1.00. The sta
KRTL MERRY NVDA
threewheeler threewheeler 4 minutes ago
KRTL liking what I.m seeing, hearing, next update can be huge
Xstocklpicker88
@xstocklpicker88
$KRTL at .046 is a #25xgem within 60 days imo. The company is an FDA registered pharma company bringing drugs from South America to the U.S. One sales news away from .046-1.00. The sta
KRTL MERRY NVDA
wronginvestor wronginvestor 4 minutes ago
This company just has too much dirty laundry, too much drama, too many x accounts, and too many issued shares to go anywhere. New PR person has only made it worse.

Only thing that's going to fix this is a massive public buyback of shares to push SP up. Money solves many issues
HIRU
europa7 europa7 5 minutes ago
FYI: info regarding Apple is suspected of being false...source of info has apparently been discredited...see links from Hedera reddit posted below...

https://www.reddit.com/r/Hedera/comments/1hlxe2r/shameless/

https://www.reddit.com/r/Hedera/comments/1hm1mqz/people_nee
HBARUSD
renaissance1 renaissance1 7 minutes ago
Can anyone update this board on the status of this company? I appreciate any info. Been here along time but have no idea if we are close to being a success or if we are stuck in the mud. Lol.
NWBO
tmcfo tmcfo 8 minutes ago
Here is the updated sample letter. Anyone here on ihub that wants to add, delete, revise is welcomed.
If Skull decides to take the lead as the signer, let’s see the other shareholders who wants to add their names to the letter once it is finalized. Let’s have a show of hands of the shareho
MVNT
wronginvestor wronginvestor 13 minutes ago
https://tinyurl.com/fn44uvt3
HIRU
Steady_T Steady_T 14 minutes ago
Did you read the linked article?
Didn't look promising to me.
AVXL
janice shell janice shell 15 minutes ago
Well... They can't really expect other people to speak Greenlandic. Which apparently is the language of 70 percent of the people who live there.
crazy horse 0 crazy horse 0 16 minutes ago
On 12/26/17 this board was created by myself and Mr40. That was Seven years ago! It seems like yesterday.

We all hope Mr40 and her little dog Remy are in good spirits and in good hands.

Thank you to all of you who read and contribute to our America Stands With Trump
renaissance1 renaissance1 17 minutes ago
What are we looking at here buddy? Thanks in advance for any information.
TMDIF
arizona1 arizona1 17 minutes ago
He's really good! It's amazing how perfectly they all speak English.
renaissance1 renaissance1 18 minutes ago
Interesting. Something is going on. It’s about time. 10 years……let’s go baby!! Maybe it’s time……good luck to all the longs that have stuck it out. Praying for good outcomes not only for us shareholders but patients as well. It can be both. Lol.
CVM
Hardazoak Hardazoak 21 minutes ago
Easy on the fetenyl rbtree. Crazy talk is the first sign we are dealing with an addict living in mommy's basement.
AABB
Hoskuld Hoskuld 21 minutes ago
AD is a huge indication. The FDA has a duty to understand 2-73 thoroughly before approving it. Investors have a completely different set of priorities and preconceptions. 2-73 (like aducamab and lecanemab) will take 12 months to review and decide.
AVXL
BDEZ BDEZ 25 minutes ago
Replacing American talent with Indians. This has been happening at a massive scale for over 2 years

https://x.com/AgueroForTexas/status/1872124657786298426
janice shell janice shell 28 minutes ago
That's outstanding! Love the guy who imitates Ahhnold.
splintered sunlight splintered sunlight 29 minutes ago
Merry Christmas AtlasQ!!!
RDGL
Rkramden Rkramden 29 minutes ago
FWIW
Cbiz acquired marcum last month

Your Recent History

Delayed Upgrade Clock